China’s Xpeng hikes price of cars following Tesla and other EV makers as raw material costs rise

China’s Xpeng hikes price of cars following Tesla and other EV makers as raw material costs rise


A Xpeng P7 electric car is on display during the 18th Guangzhou International Automobile Exhibition at China Import and Export Fair Complex on November 20, 2020 in Guangzhou, Guangdong Province of China.

VCG | Visual China Group | Getty Images

Chinese electric vehicle maker Xpeng will hike the price of its cars citing a sharp rise in the cost of raw materials.

Xpeng said from Mar. 21, price increases on its vehicles will range from 10,100 Chinese yuan ($1,587) to 20,000 yuan before subsidies. The company did not give a breakdown of the specific price rises for each of its models.

Xpeng currently sells the flagship P7 sedan, the P5 sedan and the G3 sports utility vehicle. It is gearing up to launch the G9 SUV later this year.

Electric carmakers have been struggling with rising costs of raw materials such as nickel, which is a key component of batteries. Other components such as semiconductors continue to be in short supply, providing another headwind for Xpeng and its rivals such as Nio.

Xpeng is not the first electric vehicle company to raise prices. Over the last week, Tesla has done several price hikes across various models of its cars.

Earlier this week, Warren Buffett-backed automaker BYD also raised the prices of its new energy vehicles, which includes electric cars.



Source

Chinese stocks are on fire this year, drawing big interest from foreign and domestic investors
World

Chinese stocks are on fire this year, drawing big interest from foreign and domestic investors

When Hou Yujie isn’t convincing customers to rent traditional Chinese clothing for photos at the country’s famous Forbidden City, she and her friends are checking stocks. Hou recently put 10% of her money in the market. In just a few days, she earned one month’s salary — and she’s thrilled.  “Interest rates for bank deposits […]

Read More
U.S. pharma tariffs spare India’s generic drugmakers — but leave investors jittery
World

U.S. pharma tariffs spare India’s generic drugmakers — but leave investors jittery

MUMBAI, INDIA – MARCH 3: A technician works at a Cipla laboratory March 3, 2002 in Vikhrohi, Mumbai, India. Jean-marc Giboux | 3rd Party – Misc | Getty Images Stocks of leading Indian drugmakers fell on Friday, even though the 100% U.S. tariffs on branded and patented drug imports are unlikely to affect these companies. […]

Read More
Core inflation rate held at 2.9% in August, as expected, Fed’s gauge shows
World

Core inflation rate held at 2.9% in August, as expected, Fed’s gauge shows

Core inflation was little changed in August, according to the Federal Reserve’s primary forecasting tool, likely keeping the central bank on pace for interest rate reductions ahead. The personal consumption expenditures price index posted a 0.3% gain for the month, putting the annual headline inflation rate at 2.7%, the Commerce Department reported Friday. Excluding food […]

Read More